DE60007973D1 - Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben - Google Patents

Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben

Info

Publication number
DE60007973D1
DE60007973D1 DE60007973T DE60007973T DE60007973D1 DE 60007973 D1 DE60007973 D1 DE 60007973D1 DE 60007973 T DE60007973 T DE 60007973T DE 60007973 T DE60007973 T DE 60007973T DE 60007973 D1 DE60007973 D1 DE 60007973D1
Authority
DE
Germany
Prior art keywords
grafting
matrix protein
protein compositions
mineralized tissues
enamel matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60007973T
Other languages
English (en)
Other versions
DE60007973T2 (de
Inventor
Petter Lyngstadaas
Stina Gestrelius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Straumann AG
Original Assignee
BIORA BIOEX MALMOE AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIORA BIOEX MALMOE AB filed Critical BIORA BIOEX MALMOE AB
Publication of DE60007973D1 publication Critical patent/DE60007973D1/de
Application granted granted Critical
Publication of DE60007973T2 publication Critical patent/DE60007973T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Surgery (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DE60007973T 1999-03-10 2000-03-09 Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben Expired - Lifetime DE60007973T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900337 1999-03-10
DK990337 1999-03-10
PCT/IB2000/000247 WO2000053197A1 (en) 1999-03-10 2000-03-09 Matrix protein compositions for grafting

Publications (2)

Publication Number Publication Date
DE60007973D1 true DE60007973D1 (de) 2004-03-04
DE60007973T2 DE60007973T2 (de) 2004-12-23

Family

ID=8092401

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60007973T Expired - Lifetime DE60007973T2 (de) 1999-03-10 2000-03-09 Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben

Country Status (8)

Country Link
EP (1) EP1165102B1 (de)
JP (1) JP4726300B2 (de)
AT (1) ATE258442T1 (de)
AU (1) AU2821200A (de)
DE (1) DE60007973T2 (de)
DK (1) DK1165102T3 (de)
ES (1) ES2215028T3 (de)
WO (1) WO2000053197A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097834A1 (en) * 2000-06-20 2001-12-27 Biora Ab Matrix protein compositions for dentin regeneration
US7033611B2 (en) 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
ATE374048T1 (de) * 2001-02-23 2007-10-15 Biora Bioex Ab Verwendung von matrixprotein für gesteuerte geweberegenerationen
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
EP1830863A2 (de) 2004-12-10 2007-09-12 Straumann Holding AG Proteinformulierung
US8466101B2 (en) 2009-11-02 2013-06-18 Straumann Holding Ag Purified EMD protein composition
WO2011073447A1 (en) 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
CN103153334B (zh) 2010-10-15 2016-11-16 斯特劳曼控股公司 包含pga的新的emd制剂
US9957314B2 (en) 2011-05-09 2018-05-01 Hadasit Medical Research Services And Development Ltd. Regeneration and repair of mesenchymal tissue using amelogenin
WO2015106970A1 (en) * 2014-01-17 2015-07-23 Straumann Holding Ag Process for producing emd of increased stability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672032A (en) * 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
SE454480B (sv) * 1986-09-25 1988-05-09 Lars Hammarstrom Bindningsinducerande komposition
SE461313B (sv) * 1988-03-17 1990-02-05 Biora Ab Bindningsinducerande komposition

Also Published As

Publication number Publication date
JP4726300B2 (ja) 2011-07-20
ES2215028T3 (es) 2004-10-01
DE60007973T2 (de) 2004-12-23
JP2002538212A (ja) 2002-11-12
DK1165102T3 (da) 2004-06-01
EP1165102B1 (de) 2004-01-28
ATE258442T1 (de) 2004-02-15
AU2821200A (en) 2000-09-28
WO2000053197A1 (en) 2000-09-14
EP1165102A1 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
EP1196444B8 (de) Exendin-4 konjugate und ihre medizinische verwendung
DE60038922D1 (de) Zusammensetzungen für den wiederaufbau von knochengewebe
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
WO2003064449A3 (en) Bioactive keratin peptides
AU3692001A (en) Compositions and methods for enhancing drug delivery across biological membranesand tissues
NO20022599D0 (no) Klorofyll- og bakterioklorofyllesteres, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike
FR2721198B1 (fr) Prothèse implantable souple, utilisée en chirurgie pour l'augmentation de volume ou la reconstruction des tissus mous, notamment prothèse mammaire.
TR200001977T2 (tr) Lipofilik glukokortikosteroit içeren miseller ihtiva eden bileşimler
ATE271886T1 (de) Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
PT749317E (pt) Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
DE69940635D1 (de) Copolymer-zusammensetzungen zur oralen verabreichung
NO20031159D0 (no) Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner
WO2001038303A3 (fr) Analogues de la vitamine d
ATE258442T1 (de) Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
EA200300532A1 (ru) Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке
ATE337339T1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
AU9363398A (en) Hepatitis c receptor protein cd81
AU2001274374A1 (en) Matrix protein compositions for dentin regeneration
MXPA03010628A (es) Analogos de vitamina d.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INSTITUT STRAUMANN AG, BASEL, CH